Market Trends of United Kingdom Minimally Invasive Surgery Devices Industry
This section covers the major market trends shaping the UK Minimally Invasive Surgery Devices Market according to our research experts:
Cardiovascular Segment is Expected to Hold a Significant Market Share Over the Forecast Period
The major factor driving the growth of the segment is the rising incidence of gastrointestinal diseases in the young, adult, and geriatric groups. Increasing obesity is expected to increase the burden of cardiac diseases in the country. The UK Factsheet report of the British Heart Foundation, which was released in July 2021, estimated that 7.6 million people in the United Kingdom were affected by heart and circulation disorders. According to the same source, heart and circulation disorders in the United Kingdom accounted for more than 160,000 deaths annually or 25% of all fatalities in the country. As a result, there is a growing demand for cardiac surgery in the country due to the high prevalence of heart disorders. Government assistance in the form of grants is promoting industry expansion over time. For instance, the development of the CUOREMA project by the United Kingdom-based health technology business MyHealth and its partners received a EUR 2.5 million Eurostars Grant in May 2021. The creation of a novel, patient-centered cardiac rehabilitation support system is the main goal of the CUOREMA project. Thus, such initiatives are expected to increase the market's growth.
Robotic Assisted Surgical Systems are Expected to See Significant Growth Over the Forecast Period
Factors such as the increasing prevalence of chronic diseases and initiatives by key market players are expected to boost market growth over the forecast period. There is a large number of people affected by musculoskeletal diseases in the country. For instance, as per the report published by Versus Arthritis in November 2021, over 20.3 million people in the United Kingdom were affected by musculoskeletal (MSK) conditions, such as arthritis or back pain. The disease prevalence by region is England: 17.1 million people (32%), Scotland: 1.7 million people (33%), Wales: 974,000 people (29%), and Northern Ireland: 525,000 people (29%). Thus, the increasing prevalence of such chronic disorders is expected to increase segmental growth.
Initiatives by key market players in the country are another factor driving the market growth. For instance, in October 2022, the Royal College of Surgeons of England (RCS England) unveiled a da Vinci Si robotic-assisted surgical system in the college's newly transformed headquarters for robotic-assisted surgeries.
Partnerships are another driver of market growth. For instance, in March 2022, CMR Surgical (CMR) - a global surgical robotics business, was awarded a significant multi-year contract by NHS Wales for the implementation of the Versius Surgical Robotic System in a National Robotics Assisted Surgery Programme. Under the contract terms, four Versius systems will initially be installed across several hospitals in Wales, with over 1,300 patients expected to benefit from the program annually. Thus, the increasing prevalence of chronic diseases, coupled with initiatives such as partnerships, is expected to increase the adoption of robotic-assisted surgeries, which is expected to boost segmental growth over the forecast period.
